1. Laboratory parameters and outcomes in hospitalized adults with COVID-19: a scoping review

   • Andrew Zhu
   • George Zakusilo
   • Justin J. Choi

   Review 10 July 2021 Pages: 1 - 9

   

2. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?

   • Ali Hamady
   • JinJu Lee
   • Zuzanna A. Loboda

   Review Open access 29 July 2021 Pages: 11 - 25

   

3. Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis

   • Mulugeta T. Angamo
   • Mohammed A. Mohammed
   • Gregory M. Peterson

   Review 31 July 2021 Pages: 27 - 41

   

4. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis

   • Woon Hean Chong
   • Biplab K. Saha
   • Kristoffer P. Neu

   Review 27 September 2021 Pages: 43 - 56

   

5. The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy

   • Boaz Elad
   • Leor Perl
   • Katia Orvin

   Original Paper 05 June 2021 Pages: 57 - 64

   

6. Point-of-care ultrasound to assess volume status and pulmonary oedema in malaria patients

   • Christina M. Pugliese
   • Bayode R. Adegbite
   • Martin P. Grobusch

   Original Paper Open access 10 June 2021 Pages: 65 - 82

   

7. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit

   • Alessandro Russo
   • Francesca Gavaruzzi
   • Mario Venditti

   Original Paper Open access 27 June 2021 Pages: 83 - 92

   

8. Key summary of German national treatment guidance for hospitalized COVID-19 patients

   • Jakob J. Malin
   • Christoph D. Spinner
   • Stefan Kluge

   Original Paper Open access 06 July 2021 Pages: 93 - 106

9. Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients

   • Jakob J. Malin
   • Christoph D. Spinner
   • Stefan Kluge

   Correction Open access 19 August 2021 Pages: 107 - 108

10. Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study

    • Justin Y. Lu
    • Wei Hou
    • Tim Q. Duong

    Original Paper 26 June 2021 Pages: 109 - 119

    

11. The proportion, species distribution and dynamic trends of bloodstream infection cases in a tertiary hospital in China, 2010–2019

    • Jiewei Cui
    • Meng Li
    • Zhixin Liang

    Original Paper Open access 28 June 2021 Pages: 121 - 130

    

12. Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy

    • Nandini Malshe
    • Suprabha K. Patnaik
    • Vidya Arankalle

    Original Paper 07 July 2021 Pages: 131 - 137

    

13. Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study

    • Vincenzo De Santis
    • Alberto Corona
    • Mervyn Singer

    Original Paper 14 July 2021 Pages: 139 - 148

    

14. Detection of Zika virus in urine from randomly tested individuals in Mirassol, Brazil

    • Pâmela Jóyce Previdelli da Conceição
    • Lucas Rodrigues de Carvalho
    • Paula Rahal

    Original Paper 29 July 2021 Pages: 149 - 156

    

15. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity

    • Dieter Munker
    • Tobias Veit
    • Katrin Milger

    Original Paper Open access 28 July 2021 Pages: 157 - 168

    

16. Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study

    • Qian Shen
    • Lingyan Sheng
    • Jianying Zhou

    Original Paper 05 August 2021 Pages: 169 - 178

    

17. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences

    • Eva Tabernero
    • Luis A. Ruiz
    • Rafael Zalacain

    Original Paper 31 August 2021 Pages: 179 - 189

    

18. A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital

    • Julia Jeck
    • Florian Jakobs
    • Florian Kron

    Original Paper Open access 18 August 2021 Pages: 191 - 201

    

19. A bacteraemia risk prediction model: development and validation in an emergency medicine population

    • Agustín Julián-Jiménez
    • Juan González del Castillo
    • on behalf of the INFURG-SEMES investigators

    Original Paper 06 September 2021 Pages: 203 - 221

    

20. Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease

    • Amine Benadji
    • Xavier Duval
    • SIIP Study Group

    Original Paper 01 September 2021 Pages: 223 - 233

    

21. Lobar (croupous) pneumonia: old and new data

    • Vsevolod A. Zinserling
    • Vladimir V. Swistunov
    • Angelica E. Makarova

    Original Paper 01 September 2021 Pages: 235 - 242

    

22. 16S rDNA PCR for the aetiological diagnosis of culture-negative infective endocarditis

    • Vanesa Anton-Vazquez
    • Rafal Dworakowski
    • Amanda Fife

    Original Paper 06 September 2021 Pages: 243 - 249

    

23. SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods

    • Elizabeth-Barbara Tatsi
    • Charilaos Dellis
    • Athanasios Michos

    Brief Report 05 July 2021 Pages: 251 - 256

24. Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France

    • Fabrice Carrat
    • Nathanael Lapidus
    • for the SAPRIS-SERO study group

    Brief Report Open access 25 November 2021 Pages: 257 - 262

    

25. A spark of hope: histopathological and functional recovery after critical COVID-19

    • Anna Boehm
    • Anna K. Luger
    • Judith Loeffler-Ragg

    Case Report Open access 25 August 2021 Pages: 263 - 267

    

26. A severe case of Israeli spotted fever with pleural effusion in Italy

    • Cristoforo Guccione
    • Claudia Colomba
    • Antonio Cascio

    Case Report Open access 09 September 2021 Pages: 269 - 272

    

27. Ensuring global access to COVID-19 vaccines: deployment strategies for refugees and migrants must not be forgotten

    • Danilo Buonsenso
    • Ulrich von Both

    Correspondence 28 May 2021 Pages: 273 - 275

28. Tuberculous lymphadenitis: a forgotten and delayed diagnosis in low-incidence countries

    • Victor Dahl Mathiasen
    • Troels Lillebaek
    • Christian Wejse

    Correspondence 21 June 2021 Pages: 277 - 280

    

29. Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections

    • James B. Doub
    • Eleanor Wilson

    Correspondence 30 July 2021 Pages: 281 - 283

30. Long COVID: current definition

    • César Fernández-de-las-Peñas

    Correspondence 14 September 2021 Pages: 285 - 286

31. Correction to: Worldwide literature on epidemiology of human alveolar echinococcosis: a systematic review of research published in the twenty-first century

    • Sven Baumann
    • Rong Shi
    • the interdisciplinary Echinococcosis Working Group Ulm

    Correction Open access 11 October 2021 Pages: 287 - 288